Clinical Trials Directory

Trials / Completed

CompletedNCT02402179

Metabolic Availability of Tryptophan From White Maize

Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Tryptophan From White Maize Protein, in Young Adult Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
Male
Age
20 Years – 49 Years
Healthy volunteers
Accepted

Summary

Our objective is to determine the metabolic availability of Tryptophan in white maize using the indicator amino acid oxidation (IAAO) technique in adult men.

Detailed description

Our objective is to determine the metabolic availability of Tryptophan in white maize. Seven young, healthy, male adults will receive graded levels (13.2, 26.4, 39.7, 52.9) of tryptophan requirement of 3.78 mg/kg/d as a crystalline amino acid (AA) mixture and a porridge of white cornmeal protein respectively.

Conditions

Interventions

TypeNameDescription
OTHERTryptophanTryptophan will be supplied at 13.2, 26.4, 39.7, or 52.9% of requirement; sourced from crystalline amino acid and white cornmeal maize.

Timeline

Start date
2015-03-01
Primary completion
2016-04-01
Completion
2016-05-01
First posted
2015-03-30
Last updated
2016-11-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02402179. Inclusion in this directory is not an endorsement.

Metabolic Availability of Tryptophan From White Maize (NCT02402179) · Clinical Trials Directory